|
|||||
|
|
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis |
|
| Authors: | Motoo Nomura Isao Oze Tetsuya Abe Azusa Komori Yukiya Narita Toshiki Masuishi Hiroya Taniguchi Shigenori Kadowaki Takashi Ura Masashi Andoh Ryosuke Kawai Norihisa Uemura Makoto Ishihara Tsutomu Tanaka Masahiro Tajika Yasumasa Niwa Kei Muro Manabu Muto |
| Affiliation: | 1. Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden Chikusa-ku, Nagoya, Aichi, 464-8681, Japan 2. Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan 3. Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden Chikusa-ku, Nagoya, Aichi, 464-8681, Japan 4. Department of Gastrointestinal Surgery, Aichi Cancer Center Hospital, 1-1 Kanokoden Chikusa-ku, Nagoya, Aichi, 464-8681, Japan 5. Department of Endoscopy, Aichi Cancer Center Hospital, 1-1 Kanokoden Chikusa-ku, Nagoya, Aichi, 464-8681, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |